News & Events
-
June 25, 2023 - June 29, 2023
DIA 2023 Global Annual Meeting | ILLUMINATE
The DIA 2023 Global Annual Meeting invites industry, regulatory government, academics, and patients to network, problem-solve, and discuss global and local challenges facing the life sciences community. Hosted in Boston, key C-Path personnel will be on-hand to discuss and view the many different perspectives offered at this event, while highlights expertise across the globe to...... -
April 19, 2023 - April 20, 2023
14th Annual Patient-Reported Outcome Consortium Workshop
On April 19–20, 2023, the 14th Annual Patient-Reported Outcome Consortium Workshop was held in Silver Spring, MD. The following Workshop Agenda provides an overview of the day-and-a-half-long meeting as well as links to the session recordings, slide decks, and posters presented. Agenda – April 19, 2023 7:30 – 8:30 am ET (60 min) Registration and...... -
October 13, 2022 - October 14, 2022
DIA 2022 Digital Technology in Clinical Trials Conference
Early bird rates in effect until August 18! C-Path’s eCOA Consortium is co-sponsoring the DIA 2022 Digital Technology in Clinical Trials Conference, October 13-14, 2022. This in-person conference will bring together thought leaders from regulatory agencies, biotech, pharma, patients and academia to discuss the latest advances, challenges and forward-thinking approaches for implementing digital technology to improve clinical trials.... -
February 17, 2021
WEBINAR: eCOA: Getting Better Together Initiative – An Update from C-Path’s PRO Consortium and ePRO Consortium
This webinar was hosted by the DIA Study Endpoints Community and presented jointly by the PRO Consortium and ePRO Consortium.
Date: Wednesday, February 17, 2021
-
October 29, 2020
COVID-19: Risk Assessment and Mitigation Strategies for the Collection of PRO Data through Clinical Sites – Lessons Learned
This webinar provides an update from sponsors and eCOA providers as they discuss lessons learned from managing clinical trials that originally planned for in-person collection of ePRO data through clinical sites. Due to public health concerns, many patients are either unable or unwilling to travel to sites for scheduled visits or sites have had to close. In March 2020, ePRO Consortium and PRO Consortium member representatives collaborated on risk assessment and mitigation strategies for clinical trials in response to COVID-19. This webinar discusses lessons learned, how the initial recommendations performed, and how sponsors and eCOA providers are applying these learnings to future trials …